Transgenic Polyoma middle-T mice model premalignant mammary disease

Cancer Research

Volumn 61, Issue 22, 2001, Pages 8298-8305

  Maglione, Jeannie E ^a   Moghanaki, Drew ^a   Young, Lawrence J T ^b   Manner, Cathyryne K ^a   Ellies, Lesley G ^a   Joseph, Sasha O ^a   Nicholson, Benjamin ^a   Cardiff, Robert D ^b   MacLeod, Carol L ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN P53;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST DISEASE; BREAST HYPERPLASIA; BREAST TUMOR; FEMALE; GENE EXPRESSION; MOUSE; NONHUMAN; POLYOMA VIRUS; PRECANCER; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL DIVISION; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION; PRECANCEROUS CONDITIONS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035890383     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Routinely available indicators of prognosis in breast cancer
2. The role of pathology in premalignancy and as a guide for treatment and prognosis in breast cancer
3. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999
4. The mammary gland: A unique organ for the study of development and tumorigenesis
5. Genetically engineered mouse models of mammary intraepithelial neoplasia
6. The mammary pathology of genetically engineered mice: The consensus report and recommendations from the Annapolis meeting
7. Protoneoplasia: The molecular biology of murine mammary hyperplasia
8. Transgenic mouse models of breast cancer
9. Signal transduction in mammary tumorigenesis: A transgenic perspective
10. Mammary gland neoplasia: Insights from transgenic mouse models
11. Transgenic mouse models of mammary tumorigenesis
12. Activated neu induces rapid tumor progression
13. Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease
14. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene
15. Mammary tumorigenesis and metastasis in transgenic mice
16. Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene
17. The biology of mammary transgenes: Five rules
18. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice
19. Preparing mammary gland whole mounts from mice
20. High-level synthesis of a heterologous milk protein in the mammary glands of transgenic swine
21. In situ localization of progesterone receptors in normal mouse mammary glands: Absence of receptors in the connective and adipose stroma and a heterogeneous distribution in the epithelium
22. Induction of AIDS by simian immunodeficiency virus from an African green monkey: Species-specific variation in pathogenicity correlates with the extent of in vivo replication
23. The cleared mammary fat pad and the transplantation of mammary gland morphological structures and cells
24. Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin
25. A single targeted Ets2 allele restricts development of mammary tumors in transgenic mice
26. Cytokeratin expression in breast cancer: Phenotypic changes associated with disease progression
27. Whey acidic protein extrinsically expressed from the mouse mammary tumor virus long terminal repeat results in hyperplasia of the coagulation gland epithelium and impaired mammary development
28. Expression and distribution of osteopontin in human tissues: Widespread association with luminal epithelial surfaces
29. Long term prognostic value of growth fraction determination by Ki-67 immunostaining in primary operable breast cancer
30. Prognostic value of Ki-67 compared to S-phase fraction in axillary node-negative breast cancer
31. Prognostic and predictive factors in breast cancer by immunohistochemical analysis
32. Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading
33. Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer
34. Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins
35. Differential expression of keratins 13 and 16 in normal epithelium, benign lesions, and ductal carcinomas of the human breast determined by the monoclonal antibody Ks8.12
36. Differential keratin gene expression in developing, differentiating, preneoplastic, and neoplastic mouse mammary epithelium
37. Premalignant and malignant disease of the breast: The roles of the pathologist
38. Immunohistochemical studies of early breast cancer evolution
39. Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes
40. Transgenic mice as probes into complex systems
41. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene
42. Phospatidylinositol 3-kinase expression in human breast cancer